Conference Call Announcement for Knight Therapeutics Inc.
MONTREAL — Knight Therapeutics Inc. (TSX: GUD), a prominent specialty pharmaceutical player in the Americas, is scheduled to unveil its third quarter financial results. The announcement will take place on an upcoming Thursday, prior to the market opening, allowing investors and interested parties to stay informed about the company's performance.
Details of the Conference Call
Participants are invited to join the conference call and audio webcast, which will provide insights into Knight’s financial health and strategic direction. This is an excellent opportunity for stakeholders to engage with the financial team and better understand the company's market position.
Date: Thursday, an upcoming date
Time: 8:30 a.m. ET
Telephone Access: For those wishing to participate by phone, please dial Toll-Free: 1-888-699-1199 or International at 1-416-945-7677.
Webcast Information
The conference will also be accessible via a listen-only audio webcast, making it convenient for those unable to participate by phone. A media player application may be required for an optimal listening experience.
Availability of Replay
Should you miss the live session, don’t worry—an archived replay will be available online for a month to catch up on what you might have missed. This ensures all interested individuals can stay updated on Knight’s performance.
About Knight Therapeutics Inc.
Knight Therapeutics Inc., headquartered in Montreal, Canada, stands as a specialized pharmaceutical firm dedicated to acquiring, licensing, and commercializing pharmaceutical products across Canada and Latin America. With a robust operational framework in Latin America through subsidiaries such as United Medical, Biotoscana Farma, and Laboratorio LKM, Knight aims to meet diverse healthcare needs. Its shares are publicly traded on the TSX under the ticker GUD, reflecting its growth and commitment to enhancing patient care.
Investing in the Future
Looking forward, Knight Therapeutics continues to strategize on product development, aiming to strengthen its market presence while delivering effective therapeutic solutions. Their commitment to growth is evident in their ongoing initiatives and partnerships that enhance their product offerings.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call is intended to present Knight Therapeutics' third quarter financial results and to engage with interested participants regarding the company's performance.
How can I join the conference call?
You can join the conference call by dialing the provided toll-free number or attending the live audio webcast.
Will there be an opportunity to ask questions during the call?
Yes, typically there is a Q&A segment following the presentation where participants can ask questions regarding the results.
How long will the replay be available?
The replay of the conference call will be available for 30 days for those who wish to review the discussion.
Where can I find more information about Knight Therapeutics?
More information about Knight Therapeutics can be found on their official website or through their investor relations team.